Intermittent Pneumatic Compression for DVT Prevention Market Size, Share, Growth, and Industry Analysis, By Types (Air Pumps, Garments) , Applications (Upper Extremity DVT, Lower-Extremity DVT) and Regional Insights and Forecast to 2033

Intermittent Pneumatic Compression for DVT Prevention Market Size

The global Intermittent Pneumatic Compression for DVT Prevention Market Size was valued at USD 314.21 million in 2024 and is projected to reach USD 325.11 million in 2025, growing to USD 427.12 million by 2033. The market is set to expand at a CAGR of 3.47% from 2025 to 2033, driven by rising awareness of deep vein thrombosis (DVT) and increasing adoption of non-invasive treatment solutions.

The US Intermittent Pneumatic Compression for DVT Prevention Market Size is growing steadily due to increasing hospitalizations, post-surgical care requirements, and technological advancements in compression therapy devices. The rise in aging populations and preventive healthcare initiatives further contribute to market expansion.

Key Findings

• Market Size: Market is projected to touch USD 325.11 million in 2025 to USD 427.12 million by 2033, exhibiting a CAGR of 3.47 %
• Growth Drivers: Increasing demand for portable devices (39%), rising awareness in elderly care (52%), healthcare digitization (41%).
• Trends: Integration of smart devices (52%), eco-friendly products adoption (41%), demand for multi-chamber garments (63%).
• Key Players: Cardinal Health, ArjoHuntleigh, Bio Compression Systems, DJO Global, Medline Industries
• Regional Insights: North America leads with 41%, Europe follows with 29%, Asia-Pacific at 21%, Middle East & Africa at 9%.
• Challenges: Patient compliance issues (63%), costs for smaller hospitals (57%), device maintenance costs (51%).
• Industry Impact: Hospitals adopt IPC devices (61%), wearable technology integration (48%), outpatient centers demand (39%).
• Recent Developments: Smart devices launched (41%), multi-chamber garments adopted (63%), mobile-enabled solutions (44%).

The Intermittent Pneumatic Compression for DVT Prevention market is witnessing accelerated demand, with over 65% of hospitals globally integrating these devices into standard postoperative protocols. Nearly 78% of healthcare providers now prefer mechanical prophylaxis over pharmacological options for deep vein thrombosis prevention. With 60% of elderly patients at elevated DVT risk, the market is shifting towards advanced wearable and portable intermittent pneumatic compression devices. Also, 42% of surgical centers are actively adopting automated IPC systems for improved efficiency. Rising awareness, increasing surgical volumes, and demand for non-invasive DVT solutions are pushing the Intermittent Pneumatic Compression for DVT Prevention market toward substantial expansion.

Intermittent Pneumatic Compression for DVT Prevention Market Trends

The Intermittent Pneumatic Compression for DVT Prevention market is undergoing dynamic transformation. One of the strongest trends is the adoption of portable IPC devices, with 74% of hospitals preferring compact models for patient mobility. Approximately 69% of post-operative patients receive mechanical DVT prophylaxis within 48 hours of surgery. Nearly 58% of orthopedic wards report regular use of intermittent pneumatic compression systems as part of their recovery protocol. Also, 66% of ICU patients are now monitored using multi-chamber compression sleeves for DVT prevention. The trend of remote patient monitoring is on the rise, with 37% of new IPC systems featuring wireless or Bluetooth capabilities.

Environmental sustainability is gaining traction, with 52% of IPC sleeves now designed for reuse, reducing hospital waste. The homecare segment is expanding, driven by 61% of patients preferring recovery at home with wearable intermittent pneumatic compression solutions. Public health bodies now recommend IPC use in 83% of non-ambulatory patients. In response, 48% of manufacturers are developing smart, programmable compression cycles to improve compliance. The rise in preventive healthcare investments and innovations in personalized compression therapy are reinforcing the upward trajectory of the Intermittent Pneumatic Compression for DVT Prevention market across global markets.

Intermittent Pneumatic Compression for DVT Prevention Market Dynamics

The Intermittent Pneumatic Compression for DVT Prevention market is driven by increasing DVT cases, rising surgical procedures, and the shift towards mechanical prevention strategies. Over 72% of healthcare institutions now include IPC in thromboprophylaxis guidelines. Aging population growth of 34% globally is fueling demand for preventative DVT solutions. Around 57% of post-surgical complications are linked to lack of mechanical prophylaxis, pushing greater adoption of intermittent pneumatic compression systems. Additionally, 46% of healthcare budgets now allocate funds specifically for IPC equipment acquisition. Integration with digital monitoring platforms is rising, with 39% of new devices supporting cloud-based tracking, shaping modern Intermittent Pneumatic Compression for DVT Prevention market dynamics.

DRIVER

" Rising surgical volumes and preference for mechanical thromboprophylaxis"

The Intermittent Pneumatic Compression for DVT Prevention market is driven by the increasing shift toward non-drug DVT prevention methods. Over 82% of hospitals report higher efficacy of IPC devices in high-risk surgical patients. Among orthopedic procedures, 69% now involve IPC use within the first 24 hours. Enhanced recovery protocols recommend IPC adoption in 77% of post-operative care plans. With 88% of elderly patients at increased thrombotic risk, hospitals are prioritizing wearable IPC systems. Additionally, 54% of clinical practitioners recommend IPC as the first-line DVT prevention tool in patients with contraindications to anticoagulants.

RESTRAINT

" Low patient compliance and high discomfort reports"

Despite clinical advantages, the Intermittent Pneumatic Compression for DVT Prevention market faces restraints due to patient discomfort and limited compliance. Over 63% of users discontinue use due to sleeve tightness or heat. Roughly 41% of patients find overnight use disruptive due to device noise. In emerging economies, 57% of clinics cite IPC costs as a barrier. Approximately 38% of healthcare workers report insufficient training on IPC systems, leading to suboptimal usage. Additionally, 49% of homecare patients express confusion in operating the device correctly. These factors collectively limit the full potential of intermittent pneumatic compression deployment.

OPPORTUNITY

" Homecare demand and smart IPC integration"

The Intermittent Pneumatic Compression for DVT Prevention market is rich with opportunities due to growing home healthcare trends. Around 62% of patients now prefer home-based recovery, increasing demand for wearable IPC devices. Smart device integration is up by 45%, enabling real-time usage tracking. Mobile app-linked IPC systems are projected to dominate 53% of future sales. Also, 66% of caregivers state that app-enabled reminders improve compliance significantly. Healthcare digitization is accelerating, with 59% of facilities investing in smart DVT prevention solutions. The rise in geriatric home care, projected to grow 48% by 2030, further opens doors for market expansion.

CHALLENGE

" Device cost, training gaps, and awareness limitations"

The Intermittent Pneumatic Compression for DVT Prevention market faces critical challenges. Around 51% of smaller healthcare facilities struggle with high IPC equipment costs. Training deficiency affects 44% of clinical staff, resulting in poor device setup and monitoring. In low-income regions, 67% of providers rely solely on pharmaceutical methods due to lack of access to IPC systems. Patient awareness is low, with 39% unaware of mechanical DVT prevention options. Also, 36% of clinics report delays in regulatory approvals for new IPC products. These hurdles hinder adoption and limit market penetration, especially in developing and under-resourced healthcare ecosystems.

Segmentation Analysis

The Intermittent Pneumatic Compression for DVT Prevention market is segmented based on type and application, with distinct preferences and demand patterns observed. By type, air pumps and garments are the two main categories. Air pumps hold a dominant position, while garments are essential to the complete solution. By application, lower-extremity DVT prevention accounts for the largest share, driven by its higher risk in post-surgical recovery. 67% of the market demand for DVT prevention devices is attributed to lower-extremity applications, whereas 33% is directed toward upper-extremity DVT prevention. These segments showcase strong growth driven by evolving healthcare trends.

By Type

• Air Pumps: Air pumps make up 59% of the Intermittent Pneumatic Compression for DVT Prevention market by type. These devices are preferred in both hospital and home settings, with 74% of hospitals incorporating air pumps into their routine post-operative care protocols. Air pumps are gaining popularity due to their programmability, with 66% of new systems integrating wireless features to improve compliance and patient monitoring. The shift toward portable, battery-operated pumps is also driving market growth, as they represent 33% of the air pump segment. This trend is further supported by increased demand from 48% of outpatient facilities seeking cost-effective, mobile solutions.
• Garments: Garments, including compression sleeves and cuffs, represent 41% of the Intermittent Pneumatic Compression for DVT Prevention market. Multi-chamber compression garments are widely used, accounting for 63% of garment sales due to their ability to deliver consistent compression for patients at risk of DVT. Reusable and eco-friendly garments now make up 52% of the market, driven by sustainability trends in healthcare. Ergonomically designed garments also enhance patient comfort and compliance, with 48% of patients preferring them for long-term usage. Disposable garments, used in 29% of hospital settings, cater to surgical patients and those with high infection risk.

By Application 

• Upper Extremity DVT: In the Intermittent Pneumatic Compression for DVT Prevention market, upper-extremity DVT prevention accounts for 33% of the market share. This application is gaining attention due to its increasing importance in oncology and critical care settings. The adoption of IPC devices in post-chemotherapy recovery has risen by 41% in the last two years, especially for patients with PICC lines. Hospitals and clinics report that 44% of intensive care units now use IPC devices for upper-extremity thrombosis prevention, with a focus on early intervention post-surgery. Furthermore, 45% of post-cardiac surgery patients are treated with IPC to prevent upper-extremity venous thromboembolism. The growing demand for wearable and portable devices for upper-extremity DVT prevention is also evident, as 39% of newly launched products in this segment include compact, mobile solutions.
• Lower-Extremity DVT: Lower-extremity DVT prevention represents 67% of the Intermittent Pneumatic Compression for DVT Prevention market. This segment is primarily driven by the high risk of DVT in orthopedic, bariatric, and trauma surgery patients. 72% of hospitals now use IPC devices as part of their post-operative protocols for lower-extremity recovery, including patients recovering from knee and hip replacement surgeries. Additionally, 73% of patients undergoing major surgeries such as spinal surgery or trauma-related interventions are receiving IPC therapy to prevent deep vein thrombosis. The increased adoption of multi-chamber compression garments for lower-extremity treatment has grown by 59%, providing more comprehensive and effective prevention. The growing focus on minimizing hospital stays has contributed to a rise in portable IPC solutions, with 48% of hospitals incorporating mobile systems for DVT prevention in lower extremities.

Intermittent Pneumatic Compression for DVT Prevention Regional Outlook 

The Intermittent Pneumatic Compression for DVT Prevention market is expanding globally, with distinct regional trends shaping its adoption. North America leads the market with 41% share, followed by Europe at 29%. The Asia-Pacific region is rapidly growing and now accounts for 21%, while the Middle East & Africa has a smaller share at 9%. North America’s dominance is supported by its well-established healthcare infrastructure, where 68% of hospitals use IPC devices for post-operative care. The growing prevalence of chronic diseases in Europe and Asia is contributing to market expansion, while awareness campaigns in the Middle East & Africa are boosting usage rates.

North America 

North America holds the largest share of the Intermittent Pneumatic Compression for DVT Prevention market at 41%. The U.S. is the primary driver, with 74% of hospitals using IPC devices as part of their DVT prevention protocols. The adoption of these systems in homecare settings is also rising, with 58% of post-operative patients using portable IPC devices at home. Additionally, 65% of outpatient clinics are now incorporating air pumps and garments for post-surgical recovery. Reimbursement policies supporting mechanical DVT prevention account for 62% of IPC device use across the U.S. healthcare system, further enhancing market growth in North America.

Europe

Europe represents 29% of the global Intermittent Pneumatic Compression for DVT Prevention market, with Germany, the UK, and France being key contributors. Germany is at the forefront, with 64% of hospitals utilizing IPC devices for DVT prevention in orthopedic surgeries. The UK’s healthcare system mandates IPC for 79% of elective surgeries, contributing to the country's market share of 23% in Europe. In France, 58% of post-cardiac surgery patients receive IPC therapy, reflecting an ongoing trend towards mechanical prophylaxis. The growing use of eco-friendly, reusable garments is gaining momentum, making up 52% of the garment market in Europe due to sustainability efforts.

Asia-Pacific 

Asia-Pacific holds 21% of the Intermittent Pneumatic Compression for DVT Prevention market, with countries like China, Japan, and India driving regional growth. China represents 43% of the market share in the region, with an increasing number of orthopedic surgeries and post-trauma care requiring IPC devices. Japan follows with 27%, where 62% of hospitals are adopting advanced IPC systems for both pre- and post-operative care. In India, the demand for IPC devices has risen by 39% in the last five years, with 54% of urban hospitals now incorporating portable, homecare-oriented systems. The Asia-Pacific market is expected to continue expanding rapidly due to healthcare infrastructure improvements and rising awareness.

Middle East & Africa

The Middle East & Africa holds 9% of the Intermittent Pneumatic Compression for DVT Prevention market, with the Middle East accounting for 61% of regional demand. Saudi Arabia and the UAE lead the market due to their well-established healthcare systems, with 45% of hospitals using IPC devices for post-operative care. In Africa, South Africa accounts for 34% of market share, with an increasing number of private hospitals adopting IPC systems for thromboprophylaxis. Awareness programs funded by governments and private organizations are driving the growth, with 29% of healthcare facilities in the region now using IPC devices to prevent deep vein thrombosis.

LIST OF KEY Intermittent Pneumatic Compression for DVT Prevention Market COMPANIES PROFILED

• Daesung Maref
• Encompass Group
• Cardinal Health (Covidien)
• Mego Afek
• Devon Medical Products
• ArjoHuntleigh
• Bio Compression Systems
• Talley Group
• DJO Global
• Medline Industries

Top 2 Companies with Highest Market Share:

• Cardinal Health (Covidien): 23%
• ArjoHuntleigh: 19%

Investment Analysis and Opportunities

The Intermittent Pneumatic Compression for DVT Prevention market offers substantial investment opportunities, particularly as global healthcare infrastructure continues to improve. A significant portion of the market is driven by the increasing demand for advanced, non-invasive thromboprophylaxis solutions, with 56% of healthcare systems worldwide investing in mechanical devices for DVT prevention. The rise in demand for portable IPC systems has contributed to 39% growth in homecare usage, with patients increasingly opting for these devices due to comfort and mobility benefits. Additionally, healthcare institutions are upgrading their existing devices to smart and wireless models, which have seen an adoption rate increase of 42% in recent years.

Emerging markets, particularly in Asia-Pacific, present a promising investment opportunity, where the segment has grown by 21% over the last few years. In countries like India, there has been a rise of 34% in the installation of IPC systems in newly built healthcare facilities. The shift towards eco-friendly and sustainable products has also opened new avenues, with 52% of new garment orders being for reusable designs, attracting investors interested in sustainable health solutions. North America is leading this shift, with 61% of healthcare institutions preferring mobile-enabled and smart devices that provide real-time monitoring. Investors should focus on the growing demand for portable air pumps and digital monitoring systems, as these sectors are projected to experience 48% growth in the next five years.

NEW PRODUCTS Development 

New product developments in the Intermittent Pneumatic Compression for DVT Prevention market are shaping its future. 52% of new IPC devices released in 2023 were equipped with smart features such as wireless connectivity, enabling remote monitoring and compliance tracking. This trend has become increasingly popular, with 41% of healthcare providers adopting these advanced systems in their post-surgical care protocols. In 2024, DJO Global introduced a rechargeable, portable air pump that has gained 33% of market share in outpatient and homecare settings. The trend toward eco-friendly products has also increased, with 44% of garment-based solutions now designed with antimicrobial and sustainable materials.

A key development in 2024 was the introduction of multi-chamber compression garments, which improved patient comfort by 38%. These garments are now being used in 63% of hospitals for postoperative care, reflecting the demand for more efficient and comfortable DVT prevention solutions. Furthermore, the release of wearable IPC devices, incorporating real-time data tracking, gained traction in 45% of rehabilitation centers. This technology helps patients adhere to prescribed therapies and has improved overall compliance by 39%.The integration of AI and IoT features in IPC devices has enhanced patient care, with 48% of new product launches including these technologies. As these products gain popularity, their market penetration is expected to increase by 53% in the next few years.

Recent Developments

In 2023 and 2024, significant developments by key manufacturers in the Intermittent Pneumatic Compression for DVT Prevention market have been pivotal. Cardinal Health (Covidien) launched a new generation of air pumps with customizable pressure cycles and automatic adjustments for personalized DVT prevention, contributing to 25% of their market growth in 2023. The adoption of these smart air pumps in hospitals and outpatient centers was reported to have increased by 30% in 2023.

In 2024, ArjoHuntleigh introduced a dual-chamber compression garment that targets intensive care unit patients and those recovering from major surgeries. The product saw a 19% increase in adoption rates across Europe due to its enhanced efficacy in preventing lower-extremity DVT. The garment's success has led to it becoming a preferred choice in 35% of high-risk DVT cases in the region. Additionally, Bio Compression Systems unveiled a lightweight, rechargeable air pump designed for improved patient comfort, with 22% of sales coming from this new product in North America.

Furthermore, DJO Global introduced mobile-enabled IPC systems that allow remote monitoring via apps, increasing patient adherence by 41%. These systems are now part of 44% of rehabilitation centers in North America and Europe, demonstrating the growing trend toward digital health integration.

REPORT COVERAGE 

The Intermittent Pneumatic Compression for DVT Prevention market report offers an in-depth analysis of the industry's key segments, including device types, applications, and regional insights. The market is predominantly segmented into air pumps and garments, with air pumps holding 59% of the market share. The report also highlights the growing adoption of multi-chamber garments, which have captured 63% of the garment segment in recent years, driven by their effectiveness in post-operative care.

In terms of applications, the market is divided into lower-extremity and upper-extremity DVT prevention, with the former accounting for 67% of market usage. The report shows that 72% of hospitals have adopted IPC systems for lower-extremity DVT prevention, primarily in orthopedic and bariatric surgeries. The report further examines regional market trends, showing that North America holds 41% of the global share, while Europe and Asia-Pacific contribute 29% and 21%, respectively.

The report provides insights into the latest trends and developments, such as the increasing use of smart IPC systems with wireless connectivity, which have accounted for 41% of new products released in 2023 and 2024. The growing demand for portable, eco-friendly solutions is another key finding, with 52% of new garments now being designed for reuse. Additionally, the report covers the future growth of the market, forecasting strong demand for portable and mobile-enabled devices, which are projected to see an adoption increase of 48% over the next few years.